Works by Young Rok Do

Results: 94
    1

    Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia.

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 7, p. 2310, doi. 10.3390/jcm9072310
    By:
    • Byun, Ja Min;
    • Hong, Junshik;
    • Oh, Doyeun;
    • Yhim, Ho-Young;
    • Do, Young Rok;
    • Park, Joon Seong;
    • Jung, Chul Won;
    • Yang, Deok-Hwan;
    • Won, Jong-Ho;
    • Lee, Hong Ghi;
    • Moon, Joon Ho;
    • Mun, Yeung-Chul;
    • Jo, Deog-Yeon;
    • Han, Jae Joon;
    • Lee, Je-Hwan;
    • Lee, Jae Hoon;
    • Lee, Junglim;
    • Yoon, Sung-Soo
    Publication type:
    Article
    2
    3

    Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 2, p. 684, doi. 10.4143/crt.2022.1434
    By:
    • Hyungwoo Cho;
    • Dok Hyun Yoon;
    • Dong-Yeop Shin;
    • Youngil Koh;
    • Sung-Soo Yoon;
    • Seok Jin Kim;
    • Young Rok Do;
    • Gyeong-Won Lee;
    • Jae-Yong Kwak;
    • Yong Park;
    • Min Kyoung Kim;
    • Hye Jin Kang;
    • Jun Ho Yi;
    • Kwai Han Yoo;
    • Won Sik Lee;
    • Byeong Bae Park;
    • Jae Cheol Jo;
    • Hyeon-Seok Eom;
    • Hyo Jung Kim;
    • Seong Hyun Jeong
    Publication type:
    Article
    4
    5

    Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin’s Lymphoma: A Multicenter Randomized Phase II Study by the Consortium for Improving Survival of Lymphoma (CISL).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 1, p. 304, doi. 10.4143/crt.2022.004
    By:
    • Kyoung Ha Kim;
    • Jae Hoon Lee;
    • Mark Lee;
    • Hoon-Gu Kim;
    • Young Rok Do;
    • Yong Park;
    • Sung Yong Oh;
    • Ho-Jin Shin;
    • Won Seog Kim;
    • Seong Kyu Park;
    • Jee Hyun Kong;
    • Moo-Rim Park;
    • Deok-Hwan Yang;
    • Jae-Yong Kwak;
    • Hye Jin Kang;
    • Yeung-Chul Mun;
    • Jong-Ho Won
    Publication type:
    Article
    6

    Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study.

    Published in:
    Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1268, doi. 10.4143/crt.2021.1168
    By:
    • Seong Hyun Jeong;
    • Seok Jin Kim;
    • Dok Hyun Yoon;
    • Yong Park;
    • Hye Jin Kang;
    • Youngil Koh;
    • Gyeong-Won Lee;
    • Won-Sik Lee;
    • Deok-Hwan Yang;
    • Young Rok Do;
    • Min Kyoung Kim;
    • Kwai Han Yoo;
    • Yoon Seok Choi;
    • Hwan Jung Yun;
    • Jun Ho Yi;
    • Jae-Cheol Jo;
    • Hyeon-Seok Eom;
    • Jae-Yong Kwak;
    • Ho-Jin Shin;
    • Byeong Bae Park
    Publication type:
    Article
    7
    8

    Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement.

    Published in:
    Cancer Research & Treatment, 2013, v. 45, n. 2, p. 112, doi. 10.4143/crt.2013.45.2.112
    By:
    • Byung Woog Kang;
    • Joon Ho Moon;
    • Yee Soo Chae;
    • Soo Jung Lee;
    • Jong Gwang Kim;
    • Yeo-Kyeoung Kim;
    • Je-Jung Lee;
    • Deok-Hwan Yang;
    • Hyeoung-Joon Kim;
    • Jin Young Kim;
    • Young Rok Do;
    • Keon Uk Park;
    • Hong Suk Song;
    • Ki Young Kwon;
    • Min Kyung Kim;
    • Kyung Hee Lee;
    • Myung Soo Hyun;
    • Hun Mo Ryoo;
    • Sung Hwa Bae;
    • Hwak Kim
    Publication type:
    Article
    9
    10

    Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL).

    Published in:
    Journal of Hematology & Oncology, 2012, v. 5, n. 1, p. 49, doi. 10.1186/1756-8722-5-49
    By:
    • Yu Ri Kim;
    • Jin Seok Kim;
    • Yoo Hong Min;
    • Dok HyunYoon;
    • Ho-Jin Shin;
    • Yeung-Chul Mun;
    • Yong Park;
    • Young Rok Do;
    • Seong Hyun Jeong;
    • Joon Seong Park;
    • Sung Yong Oh;
    • Suee Lee;
    • Eun Kyung Park;
    • Joung-Soon Jang;
    • Won-Sik Lee;
    • Hwe-Won Lee;
    • HyeonSeok Eom;
    • Jae-sook Ahn;
    • Jae-Heon Jeong;
    • Sun Kyung Baek
    Publication type:
    Article
    11

    Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma.

    Published in:
    International Journal of Hematology, 2025, v. 121, n. 5, p. 670, doi. 10.1007/s12185-025-03927-z
    By:
    • Ng, Soo Chin;
    • Moon, Joon-Ho;
    • Park, Sung Soo;
    • Koh, Youngil;
    • Lee, Ji Hyun;
    • Eom, Hyeon-Seok;
    • Shin, Ho-Jin;
    • Jung, Sung Hoon;
    • Do, Young Rok;
    • Wilfred, Gilbert;
    • Husin, Azlan;
    • Kim, Hyo Jung;
    • Abdul Wahid, SFadilah;
    • Lee, Myung-Won;
    • Heo, Hye-won;
    • Kim, Kihyun;
    • Chuncharunee, Suporn
    Publication type:
    Article
    12
    13
    14

    Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone.

    Published in:
    International Journal of Hematology, 2021, v. 113, n. 1, p. 81, doi. 10.1007/s12185-020-02988-6
    By:
    • Lee, Ho Sup;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Yoon, Sung-Soo;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon-Seok;
    • Yoon, Dok Hyun;
    • Lee, Yoojin;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Jo, Jae-Cheol;
    • Lee, Won Sik;
    • Do, Young Rok;
    • Mun, Yeung-Chul;
    • Lee, Mark Hong;
    • Kim, Hyo Jung;
    • Kim, Sung-Hyun;
    • Kim, Min Kyoung;
    • Lim, Sung-Nam
    Publication type:
    Article
    15
    16

    Waldeyer's ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL).

    Published in:
    International Journal of Hematology, 2012, v. 96, n. 5, p. 631, doi. 10.1007/s12185-012-1200-0
    By:
    • Oh, Sung;
    • Kim, Won;
    • Kim, Jin;
    • Kim, Seok;
    • Lee, Suee;
    • Lee, Dae;
    • Lee, Soon;
    • Kang, Hye;
    • Choi, Chul;
    • Park, Jinny;
    • Song, Moo;
    • Kim, Hyo;
    • Kwon, Jung;
    • Kwak, Jae-Yong;
    • Bae, Sung;
    • Park, Byeong-Bae;
    • Do, Young-Rok;
    • Lee, Ho;
    • Jeong, Seong;
    • Suh, Cheolwon
    Publication type:
    Article
    17
    18
    19

    Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 12, p. 1280, doi. 10.1002/ajh.24891
    By:
    • Cho, Hyungwoo;
    • Yoon, Dok Hyun;
    • Lee, Jung Bok;
    • Kim, Sung-Yong;
    • Moon, Joon Ho;
    • Do, Young Rok;
    • Lee, Jae Hoon;
    • Park, Yong;
    • Lee, Ho Sup;
    • Eom, Hyeon Seok;
    • Shin, Ho-Jin;
    • Min, Chang-Ki;
    • Kim, Jin Seok;
    • Jo, Jae-Cheol;
    • Kang, Hye Jin;
    • Mun, Yeung-Chul;
    • Lee, Won Sik;
    • Lee, Je-Jung;
    • Suh, Cheolwon;
    • Kim, Kihyun
    Publication type:
    Article
    20

    Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 6, p. 449, doi. 10.1002/ajh.23427
    By:
    • Lee, Sung-Eun;
    • Choi, Soo Young;
    • Bang, Ju-Hee;
    • Kim, Soo-Hyun;
    • Jang, Eun-jung;
    • Byeun, Ji-Young;
    • Park, Jin-Eok;
    • Jeon, Hye-Rim;
    • Oh, Yun Jeong;
    • Kim, Hyeoung-Joon;
    • Kim, Yeo-Kyeoung;
    • Park, Joon Seong;
    • Jeong, Seong Hyun;
    • Kim, Sung-Hyun;
    • Zang, Dae Young;
    • Oh, Sukjoong;
    • Koo, Dong Hoe;
    • Kim, Hawk;
    • Do, Young Rok;
    • Kwak, Jae-Yong
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 863, doi. 10.1007/s00280-007-0433-8
    By:
    • Jong Gwang Kim;
    • Sang Kyun Sohn;
    • Hong Suk Song;
    • Ki-Young Kwon;
    • Young Rok Do;
    • Kyung Hee Lee;
    • Myung Soo Hyun;
    • Hun Mo Ryoo;
    • Sung Hwa Bae;
    • Keon Uk Park;
    • Jin Ho Baek;
    • Won Sik Lee;
    • Joo Seop Chung;
    • Goon Jae Cho;
    • Chang-Hak Sohn;
    • Jung Soon Jang;
    • Ho Young Chung;
    • Wansik Yu
    Publication type:
    Article
    30

    Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: A nationwide cohort study by the Korean Multiple Myeloma Working Party (KMM 2202).

    Published in:
    HemaSphere, 2024, v. 8, n. 1, p. 1, doi. 10.1002/hem3.33
    By:
    • Hyungwoo Cho;
    • Kihyun Kim;
    • Sang Eun Yoon;
    • Sung-Hoon Jung;
    • Je-Jung Lee;
    • Joon Ho Moon;
    • Hee Jeong Cho;
    • Ho Sup Lee;
    • Ka-Won Kang;
    • Sung-Yong Kim;
    • Hyeon-Seok Eom;
    • Yeung-Chul Mun;
    • Young Hoon Park;
    • Sung-Soo Yoon;
    • Young Rok Do;
    • Won Sik Lee;
    • Chang-Ki Min;
    • Dok Hyun Yoon
    Publication type:
    Article
    31
    32
    33

    P1118: LONGER FOLLOW‐UP FROM THE PIVOTAL EPCORE NHL‐1 TRIAL REAFFIRMS SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000971368.08106.5c
    By:
    • Jurczak, Wojciech;
    • Ghesquieres, Herve;
    • Karimi, Yasmin;
    • Cheah, Chan;
    • Roost Clausen, Michael;
    • Cunningham, David;
    • Rok Do, Young;
    • Lewis, David;
    • Gasiorowski, Robin;
    • Min Kim, Tae;
    • Poel, Marjolein Van Der;
    • Limei Poon, Michelle;
    • Feldman, Tatyana;
    • Linton, Kim;
    • Sureda, Anna;
    • Hutchings, Martin;
    • Kanoun, Salim;
    • Vercellino, Laetitia;
    • Cota Stirner, Mariana;
    • Mcgoldrick, Stephanie
    Publication type:
    Article
    34

    S229: PROPHYLACTIC EFFICACY OF INTRATHECAL VERSUS INTRAVENOUS METHOTREXATE FOR CNS RELAPSE IN HIGH‐RISK DIFFUSE LARGE B CELL LYMPHOMA: A PHASE III RANDOMIZED, CONTROLLED STUDY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000967828.60026.bd
    By:
    • Yahng, Seung‐Ah;
    • Yhim, Ho‐Young;
    • Kwak, Jae‐Yong;
    • Shin, Ho‐Jin;
    • Moon, Joon Ho;
    • Eom, Hyeon‐Seok;
    • Kang, Ka‐Won;
    • Park, Yong;
    • Kim, Min Kyoung;
    • Lee, Se Ryun;
    • Kim, Dae Sik;
    • Kim, Hyo Jung;
    • Yi, Jun Ho;
    • Do, Young Rok;
    • Kang, Hye Jin;
    • Lim, Sungnam;
    • Yang, Deok Hwan
    Publication type:
    Article
    35
    36
    37
    38
    39

    Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 2, p. 341, doi. 10.3109/10428194.2015.1049166
    By:
    • Park, Joon Seong;
    • Lee, Sung-Eun;
    • Jeong, Seong Hyun;
    • Jang, Eun-Jung;
    • Choi, Mi-Yeon;
    • Kim, Hyeoung-Joon;
    • Kim, Yeo-Kyeoung;
    • Kim, Sung-Hyun;
    • Zang, Dae Young;
    • Oh, Sukjoong;
    • Koo, Dong Hoe;
    • Kim, Hawk;
    • Do, Young Rok;
    • Kwak, Jae-Yong;
    • Kim, Jeong-A;
    • Kim, Dae-Young;
    • Mun, Yeung-Chul;
    • Lee, Won Sik;
    • Chang, Myung Hee;
    • Park, Jinny
    Publication type:
    Article
    40

    Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 4, p. 1020, doi. 10.3109/10428194.2014.946027
    By:
    • Lee, Gyeong-Won;
    • Go, Se-Il;
    • Kim, Seok-Hyun;
    • Hong, Junshik;
    • Kim, Yu Ri;
    • Oh, Sukjoong;
    • Kim, Sung-Yong;
    • Do, Young Rok;
    • Lee, Hyewon;
    • Lee, Soon Il;
    • Bae, Sung Hwa;
    • Oh, Sung Yong;
    • Song, Moo Kon;
    • Lee, Won-Sik;
    • Lee, Bohee;
    • Kim, Jin Seok;
    • Kim, Min Kyoung;
    • Kang, Hye Jin;
    • Ahn, Jae-Sook;
    • Yhim, Ho-Young
    Publication type:
    Article
    41
    42
    43
    44

    A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 13, p. 2274, doi. 10.1007/s00259-018-4093-1
    By:
    • Yhim, Ho-Young;
    • Kwak, Jae-Yong;
    • Kim, Keunyoung;
    • Choi, Yoon Seok;
    • Kim, Kunho;
    • Kim, Min Kyoung;
    • Kong, Eunjung;
    • Kim, Dae Sik;
    • Eo, Jae Seon;
    • Lee, Ji Hyun;
    • Kang, Do-Young;
    • Lee, Won Sik;
    • Lee, Seok Mo;
    • Do, Young Rok;
    • Ham, Jun Soo;
    • Kim, Seok Jin;
    • Kim, Won Seog;
    • Choi, Joon Young;
    • Yang, Deok-Hwan;
    • Park, Yong
    Publication type:
    Article
    45
    46
    47

    Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47198-4
    By:
    • Changhee Park;
    • Ho Sup Lee;
    • Ka-Won Kang;
    • Won-Sik Lee;
    • Young Rok Do;
    • Jae-Yong Kwak;
    • Ho-Jin Shin;
    • Sung-Yong Kim;
    • Jun Ho Yi;
    • Sung-Nam Lim;
    • Jeong-Ok Lee;
    • Deok-Hwan Yang;
    • Hun Jang;
    • Byoungsan Choi;
    • Jiwoo Lim;
    • Choong Hyun Sun;
    • Ja Min Byun;
    • Sung-Soo Yoon;
    • Youngil Koh
    Publication type:
    Article
    48

    Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).

    Published in:
    Annals of Hematology, 2023, v. 102, n. 8, p. 2233, doi. 10.1007/s00277-023-05308-0
    By:
    • Kim, Mihee;
    • Lee, Je-Jung;
    • Min, Chang-Ki;
    • Lee, Ji Yun;
    • Jo, Jae-Cheol;
    • Yoon, Sung-Soo;
    • Lim, Sung-Nam;
    • Do, Young Rok;
    • Kim, Kihyun;
    • Lee, Jae Hoon;
    • Yoo, Kwai Han;
    • Bae, Sung Hwa;
    • Yi, Jun Ho;
    • Jung, Jongheon;
    • Eom, Hyeon-Seok;
    • Jung, Sung-Hoon
    Publication type:
    Article
    49

    Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 8, p. 2051, doi. 10.1007/s00277-021-04407-0
    By:
    • Lee, Ji Hyun;
    • Park, Yong;
    • Kang, Ka-Won;
    • Lee, Je-Jung;
    • Lee, Ho Sup;
    • Eom, Hyeon-Seok;
    • Do, Young Rok;
    • Kim, Jin Seok;
    • Yoon, Sung-Soo;
    • Shin, Dong-Yeop;
    • Koh, Youngil;
    • Kim, Ki-Hyun;
    • Lee, Won Sik;
    • Jo, Jae-Cheol;
    • Lee, Yoo Jin;
    • Lee, Ji Yun;
    • Kim, Dae Sik;
    • Shim, Hyeok;
    • Chang, Myung Hee;
    • Kim, Sung-Hyun
    Publication type:
    Article
    50

    A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis.

    Published in:
    2020
    By:
    • Yoon, Sang Eun;
    • Kim, Seok Jin;
    • Yoon, Dok Hyun;
    • Koh, Youngil;
    • Mun, Yeung-Chul;
    • Do, Young Rok;
    • Choi, Yoon Seok;
    • Yang, Deok Hwan;
    • Kim, Min Kyoung;
    • Lee, Gyeong-Won;
    • Suh, Cheolwon;
    • Ko, Young Hyeh;
    • Kim, Won Seog
    Publication type:
    journal article